Jump to content
May 2024 Challenge

RR1

Members - Bounced Email
 View Profile  See their activity

  • Posts

    992

  • Joined

  • Last visited

  • Days Won

    6

  • Country

    United Kingdom

 Content Type 

Topics posted by RR1

  1.  

    Re-testing antibody screens 1 2

    By RR1, in Transfusion Services

    • 34 replies
    • 13,845 views
  2.  

    General Quality systems stuff

    By RR1, in Quality

    • 2 replies
    • 2,366 views
  3.  

    Antibody ID methodology

    By RR1, in Transfusion Services

    • 8 replies
    • 5,912 views
  4.  

    Help!!!!

    By RR1, in Quality

    • 9 replies
    • 4,404 views
  5.  

    Cold Chain

    By RR1, in Quality

    • 7 replies
    • 4,520 views
  6.  

    'Disappearing antibodies'

    By RR1, in Equipment

    • 11 replies
    • 2,831 views
  7.  

    Haemovigilance, Biovigilance, SABRE

    By RR1, in Quality

    • 9 replies
    • 5,784 views
  8.  

    CAPA / Deviation 1 2

    By RR1, in Quality

    • 44 replies
    • 22,606 views
  9.  

    Change Control 1 2

    By RR1, in Quality

    • 45 replies
    • 20,295 views
  10.  

    Automation Reagent Controls

    By RR1, in Equipment

    • 5 replies
    • 2,601 views
  11.  

    Training

    By RR1, in Quality

    • 5 replies
    • 3,216 views
  12.  

    Validation

    By RR1, in Quality

    • 17 replies
    • 8,464 views
  13.  

    Thanks to BBT site administrators

    By RR1, in Quality

    • 2 replies
    • 2,248 views
  14.  

    Audit Templates

    By RR1, in Education / Quality

    • 1 reply
    • 2,227 views
  15.  

    Typenex ID bands

    By RR1, in Transfusion Services

    • 10 replies
    • 4,490 views
  16.  

    Reagent Handling

    By RR1, in Equipment

    • 11 replies
    • 5,170 views
  17.  

    Reproducibility of Screening results

    By RR1, in Equipment

    • 1 reply
    • 1,579 views
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.